December 11, 2012 | The Street has nominated four biotech CEOs for the title of Best Biotech CEO of 2012. The heads of Onyx Pharmaceuticals, Gilead Sciences, Regeneron Pharmaceuticals, and Sarepta Therapeutics all led their companies to success, even when the pundits predicted otherwise. The Street.